Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

被引：0
|
作者：
Jan J. De Waele
J. Lipman
M. Akova
M. Bassetti
G. Dimopoulos
M. Kaukonen
D. Koulenti
C. Martin
P. Montravers
J. Rello
A. Rhodes
A. A. Udy
T. Starr
S. C. Wallis
J. A. Roberts
机构：
[1] Ghent University Hospital,Department of Critical Care Medicine
[2] The University of Queensland,Burns Trauma and Critical Care Research Centre
[3] Royal Brisbane and Women’s Hospital,Attikon University Hospital
[4] Hacettepe University Hospital,Department of Epidemiology and Preventive Medicine, Monash University
[5] Azienda Ospedaliera Universitaria Santa Maria della Misericordia,CIBERES
[6] University of Athens Medical School,Department of Intensive Care and Hyperbaric Medicine
[7] Helsinki University Hospital,undefined
[8] Australian and New Zealand Intensive Care Research Centre (ANZIC RC),undefined
[9] Hospital Nord,undefined
[10] Centre Hospitalier Universitaire Bichat-Claude Bernard,undefined
[11] Vall d’Hebron Institut of Research,undefined
[12] St George’s Healthcare NHS Trust and St George’s University of London,undefined
[13] The Alfred Hospital,undefined
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
β-Lactam antibiotics; Pharmacokinetics; Pharmacodynamics; Critical care;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1340 / 1351
页数：11
相关论文
共 50 条
  • [41] Acute Acalculous Cholecystitis in Critically ill Patients: Risk Factors, Diagnosis and Treatment Strategies
    de Oliveira Junior, Senival Alves
    Veras Lemos, Thiago Emanuel
    de Medeiros Junior, Arnaldo Costa
    Freire, Artur Dantas
    Garcia, Cesar de Carvalho
    de Sousa e Silva, Rielly
    Meneses Rego, Amalia Cinthia
    Araujo Filho, Irami
    JOURNAL OF THE PANCREAS, 2016, 17 (06): : 580 - 586
  • [42] Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion
    Tournayre, Sarah
    Mathieu, Olivier
    Villiet, Maxime
    Besnard, Noemie
    Brunot, Vincent
    Daubin, Delphine
    Platon, Laura
    Corne, Philippe
    Klouche, Kada
    Larcher, Romaric
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
  • [43] A Target for Increased Mortality Risk in Critically Ill Patients: The Concept of Perpetuity
    Mosier, Jarrod M.
    Fisher, Julia M.
    Hypes, Cameron D.
    Bedrick, Edward J.
    Campbell, Elizabeth Salvagio
    Lutrick, Karen
    Cairns, Charles B.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [44] Risk factors for decreased teicoplanin trough concentrations during initial dosing in critically ill patients
    Yoshida, T.
    Yoshida, S.
    Okada, H.
    Suzuki, A.
    Niwa, T.
    Suzuki, K.
    Ohmori, T.
    Kobayashi, R.
    Baba, H.
    Suzuki, K.
    Murakami, N.
    Itoh, Y.
    Ogura, S.
    PHARMAZIE, 2019, 74 (02): : 120 - 124
  • [45] Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review
    Gras-Martin, Laura
    Plaza-Diaz, Adrian
    Zarate-Tamames, Borja
    Vera-Artazcoz, Paula
    Torres, Olga H.
    Bastida, Carla
    Soy, Dolors
    Ruiz-Ramos, Jesus
    ANTIBIOTICS-BASEL, 2024, 13 (09):
  • [46] Incidence and risk factors of post-extubation dysphagia in non-neurological critically ill patients
    Martinez, Daniela Manriquez
    Leon, Karina Sandoval
    Cuenca, Sebastian Guajardo
    Marcotti, Anthony
    REVISTA DE INVESTIGACION EN LOGOPEDIA, 2024, 14 (01):
  • [47] Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance
    Rizk, Nesrine A.
    Kanafani, Zeina A.
    Tabaja, Hussam Z.
    Kanj, Souha S.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2017, 15 (07) : 645 - 652
  • [48] Analysis of risk factors for adverse drug events in critically ill patients
    Kane-Gill, Sandra L.
    Kirisci, Levent
    Verrico, Margaret M.
    Rothschild, Jeffrey M.
    CRITICAL CARE MEDICINE, 2012, 40 (03) : 823 - 828
  • [49] Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment
    Klastrup, Vibeke
    Thorsted, Anders
    Storgaard, Merete
    Christensen, Steffen
    Friberg, Lena E.
    Obrink-Hansen, Kristina
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [50] Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected Pseudomonas aeruginosa Infection
    Buning, Annabel Werumeus
    Hodiamont, Caspar J.
    Lechner, Natalia M.
    Schokkin, Margriet
    Elbers, Paul W. G.
    Juffermans, Nicole P.
    Mathot, Ron A. A.
    de Jong, Menno D.
    van Hest, Reinier M.
    ANTIBIOTICS-BASEL, 2021, 10 (06):
12345